References
Endres DB (2012) Investigation of hypercalcemia. Clin Biochem 45:954–963
Youdale SW, Gatell Artigas JM, Marin ES, Garcia San Miguel J (1980) Hipercalcemia como primera manifestación de une tirotoxicosis. Med Clin (Barcelona) 74:107–108
Iqbal AA, Burgess EH, Gallina DL, Nanes MS, Cook CB (2003) Hypercalcemia in hyperthyroidism: patterns of serum calcium, parathyroid hormone, and 1,25-dihydroxyvitamin D3 levels during management of thyrotoxicosis. Endocr Pract 9:517–521
Gunton JE, Stiel J, Clifton-Bligh P, Wilmshurst E, McElduff A (2000) Prevalence of anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication. Eur J Endocrinol 142:587–590
Khan NA, Singh M (2012) Development of anti-neutrophil cytoplasmic antibody-associated vasculitis in a patient with Graves’ disease independent of anti-thyroid drug therapy. Mod Rheumatol 22:778–782
Graves TK, Olivier NB, Nachreiner RF, Kruger JM, Walshaw R, Stickle RL (1994) Changes in renal function associated with treatment of hyperthyroidism in cats. Am J Vet Res 55:1745–1749
Rodríguez-Gómez I, Banegas I, Wangensteen R, Quesada A, Jiménez R, Gómez-Morales M, O’Valle F, Duarte J, Vargas F (2013) Influence of thyroid state on cardiac and renal capillary density and glomerular morphology in rats. J Endocrinol 216:43–51
Bradley SE, Stéphan F, Coelho JB, Réville P (1974) The thyroid and the kidney. Kidney Int 6:346–365
Acknowledgment
The author gratefully acknowledges Mitchell E. Geffner, M.D., for critical reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
This refers to the article that can be found at http://dx.doi.org/10.1007/s00467-013-2611-8.
Rights and permissions
About this article
Cite this article
Lemley, K.V. An unusual case of hypercalcemia in a patient with renal insufficiency: Answer. Pediatr Nephrol 29, 1531–1533 (2014). https://doi.org/10.1007/s00467-013-2627-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-013-2627-0